Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2463-2471

  Grossi, P A ^a,b   Gasperina, D Dalla ^a   Barchiesi, F ^c   Biancofiore, G ^d   Carafiello, G ^a   De Gasperi, A ^e   Sganga, G ^f   Menichetti, F ^d   Montagna, M T ^g   Pea, F ^h   Venditti, M ⁱ   Viale, P ^j   Viscoli, C ^k   Costa, A Nanni ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b National Centre for Transplantation   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h UNIVERSITY OF UDINE   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; CASPOFUNGIN; ECHINOCANDIN; EVEROLIMUS; FLUCONAZOLE; GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; MICAFUNGIN; POSACONAZOLE; RAPAMYCIN; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLOSIS; CANDIDEMIA; CANDIDIASIS; CHEMOPROPHYLAXIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FUNGAL COLONIZATION; FUNGAL GENE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INVASIVE ASPERGILLOSIS; LOADING DRUG DOSE; LUNG TRANSPLANTATION; MICROBIAL SENSITIVITY TEST; NEPHROTOXICITY; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS; UNSPECIFIED SIDE EFFECT;

ANTIFUNGAL AGENTS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; MYCOSES; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 80051692909     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.020     Document Type: Article

References (63)

1. J.A. Fishman Infection in solid-organ transplant recipients N Engl J Med 357 2007 2601
2. J.A. Fishman ATS Infectious Diseases Community of Practice Introduction: infection in solid-organ transplant recipients Am J Transplant 9 2009 S3
3. F.P. Silveira, and S. Husain Fungal infections in solid organ transplantation Med Mycol 45 2007 305
4. M.A. Pfaller, P.G. Pappas, and J.R. Wingard Invasive fungal pathogens: current epidemiological trends Clin Infect Dis 43 2006 S3
5. P.G. Pappas, B.D. Alexander, and D.R. Andes Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 2010 1101
6. Fungal infections Am J Transplant 4 2004 110
7. P.G. Pappas, C.A. Kauffman, and D. Andes Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America Clin Infect Dis 48 2009 503
8. T.J. Walsh, E.J. Anaissie, and D.W. Denning Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327
9. P.G. Pappas, F.P. Silveira ATS Infectious Diseases Community of Practice Candida in solid organ transplant recipients Am J Transplant 9 2009 S173
10. N. Singh, S. Husain ATS Infectious Diseases Community of Practice Invasive aspergillosis in solid organ transplant recipients Am J Transplant 9 2009 S180
11. B.M. Kubak, S.S. Huprikar ATS Infectious Diseases Community of Practice Emerging & rare fungal infections in solid organ transplant recipients Am J Transplant 9 2009 S208
12. B. De Pauw, T.J. Walsh, and J.P. Donnelly Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813
13. F.P. Silveira, and S. Husain Fungal infections in lung transplant recipients Curr Opin Pulm Med 14 2008 211
14. N. Singh, and S. Husain Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management J Heart Lung Transplant 22 2003 258
15. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosisusing a galactomannan assay: a meta-analysis Clin Infect Dis 42 2006 1417
16. S. Husain, D.L. Paterson, and S.M. Studer Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients Transplantation 83 2007 1330
17. C.J. Clancy, R.A. Jaber, and H.L. Leather Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients J Clin Microbiol 45 2007 1759
18. S. Husain, C.J. Clancy, and M.H. Nguyen Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid Clin Vaccine Immunol 15 2008 1760
19. L. Ostrosky-Zeichner, B.D. Alexander, and D.H. Kett Multicenter clinical evaluation of the (1 >3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 2005 654
20. F. Persat, S. Ranque, and F. Derouin Contribution of the (1>3)-beta-D-glucan assay for diagnosis of invasive fungal infections J Clin Microbiol 46 2008 1009
21. T. Obayashi, K. Negishi, and T. Svzvki Reappraisal of the serum(1>3)-beta-D-glucan based assay for the diagnosis of invasive fungal infections-A study based on autopsy cases from 6 years Clin Infect Dis 46 2008 1864
22. D.C. Saha, D.L. Goldman, and X. Shao Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients Clin Vaccine Immunol 14 2007 1550
23. N. Singh, B.D. Alexander, and O. Lortholary Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen Clin Infect Dis 46 2008 e12
24. N. Singh, G. Forrest ATS Infectious Diseases Community of Practice Cryptococcosis in solid organ transplant recipients Am J Transplant 9 2009 S192
25. M.J. Espy, J.R. Uhl, and L.M. Sloan Real-time PCR in clinical microbiology: applications for routine laboratory testing Clin Microbiol Rev 19 2006 165
26. P. Grossi, J.A. Fishman ATS Infectious Diseases Community of Practice Donor-derived infections in solid organ transplant recipients Am J Transplant 9 2009 S19
27. M.S. Saag, R.J. Graybill, and R.A. Larsen Practice guidelines for the management of cryptococcal disease Clin Infect Dis 30 2000 710
28. D. Caillot, J.F. Couaillier, and A. Bernard Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia J Clin Oncol 19 2001 253
29. D.L. Paterson, and N. Singh Invasive aspergillosis in transplant recipients Medicine (Baltimore) 78 1999 123
30. M. Aribandi, V.A. McCoy, and C. Bazan Imaging features of invasive and noninvasive fungal sinusitis: a review Radiographics 27 2007 1283
31. U. Metser, M.A. Haider, and M. Dill-Macky Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT Radiology 235 2005 97
32. R.C. Semelka, J.P. Shoenut, and H.M. Greenberg Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging Magn Reson Imaging 2 1992 341
33. R.C. Semelka, N.L. Kelekis, and S. Sallah Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging AJR Am J Roentgenol 169 1997 1311
34. P. Grossi Clinical aspects of invasive candidiasis in solid organ transplant recipients Drugs 69 2009 15
35. M. Cruciani, C. Mengoli, and M. Malena Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis Liver Transpl 12 2006 850
36. E.G. Playford, A.C. Webster, and T.C. Sorell Antifungal agents for preventing fungal infections in solid organ transplant recipients Cochrane Database Syst Rev 3 2004 CD004291
37. S.M. Palmer, R.H. Drew, and J.D. Whitehouse Safety of aerosolized amphotericin B lipid complex in lung transplant recipients Transplantation 72 2001 545
38. C. León, S. Ruiz-Santana, P. Saavedra EPCAN Study Group A bedside scoring system ("Candida score") for early antifungaltreatment in nonneutropenic critically ill patients with Candidacolonization Crit Care Med 34 2006 730
39. C. León, S. Ruiz-Santana, P. Saavedra Cava Study Group Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study Crit Care Med 37 2009 1624
40. A.H. Saad, D.D. DePestel, and P.L. Carver Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants Pharmacotherapy 26 2006 1730
41. J. Mora-Duarte, R. Betts, and C. Rotstein Comparison of caspofunginand amphotericin B for invasive candidiasis N Engl J Med 347 2002 2020
42. A.C. Reboli, C. Rotstein, and P.G. Pappas Anidulafungin versus fluconazole for invasive candidiasis N Engl J Med 356 2007 2472
43. P.G. Pappas, C.M. Rotstein, and R.F. Betts Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis Clin Infect Dis 45 2007 883
44. T.J. Walsh Echinocandins-an advance in the primary treatment of invasive candidiasis N Engl J Med 347 2002 2070
45. N.P. Weiderhold, and R.E. Lewis The echinocandin antifungals: an overview of the pharmacology, spectrum, and clinical efficacy Expert Opin Investig Drugs 12 2003 1313
46. M.A. von Mach, J. Burhenne, and L.S. Weilemann Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy BMC Clin Pharmacol 6 2006 6
47. I. Mohammedi, M.A. Piens, and C. Padoin Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients Eur J ClinMicrobiol Infect Dis 24 2005 358
48. A. Pascual, T. Calandra, and S. Bolay Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes Clin Infect Dis 46 2008 201
49. N. Singh, A.P. Limaye, and G. Forrest Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study Transplantation 81 2006 320
50. M.R. Carby, M.E. Hodson, and N.R. Banner Refractory pulmonary aspergillosis treated with caspofungin after heart-lung transplantation Transpl Int 17 2004 545
51. E. Forestier, V. Remy, and O. Lesens A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole Eur J Clin Microbiol Infect Dis 24 2005 347
52. T.J. Walsh, I. Raad, and T.F. Patterson Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial Clin Infect Dis 44 2007 2
53. D.W. Denning, K.A. Marr, and W.M. Lau Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis J Infect 53 2006 337
54. B.A. Lodge, E.D. Ashley, and M.P. Steele Aspergillus fumigatus emphysema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole J Clin Microbiol 42 2004 1376
55. S. Sandur, S.M. Gordon, and A.C. Mehta Native lung pneumonectomy for invasive pulmonary aspergillosis following lung transplantation: a case report J Heart Lung Transplant 18 1999 810
56. S. Husain, B.D. Alexander, and P. Munoz Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi Clin Infect Dis 37 2003 221
57. H.Y. Sun, G. Forrest, and K.L. Gupta Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients Transplantation 90 2010 85
58. S.-A. Chen, E.G. Playford, and T. Sorrell Antifungal therapy in invasive fungal infections Current Opinion Pharmacol 10 2010 1
59. R.N. Greenberg, K. Mullane, and J.A. Van Burik Posaconazole as salvage therapy for zygomycosis Antimicrob Agents Chemother 50 2006 126
60. A.S. Ibrahim, T. Gebremariam, and J. Schwartz Posaconazole mono-or combination therapy for treatment of murine zygomycosis Antimicrob Agents Chemother 53 2009 772
61. A. Alastruey-Izquierdo, M. CuencaEestella, and A. Monzon Antifungal susceptibility profile of clinical Fusarium spp. isolates J Antimicrob Chemother 61 2008 805
62. M. Nucci, and E. Anaissie Fusarium infections in immunocompromised patients Clin Microbiol Rev 30 2007 695
63. J.R. Perfect, K.A. Marr, and T.J. Walsh Voriconazole treatment for less-common, emerging, or refractory fungal infections Clin Infect Dis 36 2003 1122